Exploring the Mechanisms of Neuroinflammation: Impacts on Alzheimer's Disease Progression and Treatment Approaches
DOI:
https://doi.org/10.61841/s2v9zz53Keywords:
Alzheimer's, Cytokines, bloodAbstract
Background: Alzheimer’s Disease (AD) is a neurodegenerative disease characterized by progressive cognitive impairment, and neuroinflammation has become a significant cause of it. Chronic activation of microglia and elevated pro-inflammatory cytokines, including Tumor Necrosis Factor-alpha (TNF-), Interleukin-1 beta (IL-1), and Interleukin-6 (IL-6), have all been linked to AD progression. In this experiment, we questioned the association between peripheral inflammatory markers and cognitive decline in AD patients.
Methods: We carried out a cross-sectional study with 50 Alzheimer’s Disease patients. We collected peripheral blood for TNF-, IL-1, and IL-6. They measured brain function with the Mini-Mental State Examination (MMSE) and Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog). Data were then analyzed to investigate relationships between cytokine production and cognition at various stages of AD.
Results: The researchers measured significantly higher TNF-, IL-1, and IL-6 in AD patients than in controls of the same age. Symptoms of AD were more severe, and cytokine levels were highest in patients with severe AD, which was strongly correlated with cognitive loss (MMSE: r = -0.68, p 0.01; ADAS-Cog: r = 0.74, p 0.01). The association of cytokine levels with disease activity shows that neuroinflammation contributes to cognitive decline in AD.
Conclusion: This work also confirms that elevated peripheral cytokine levels are associated with cognitive decline in Alzheimer’s Disease (AD). These findings are evidence for the possibility that neuroinflammation is a cause of AD progression and for how neuroinflammation can be cured by targeting it. Explicit causal research at a longitudinal scale would be needed to understand why neuroinflammation is a cause of AD and why anti-inflammatory drugs slow cognitive decline.
Downloads
References
1. Fiala, M., & Liu, X. (2002). Inflammation and Alzheimer’s disease. Current Alzheimer Research, 7(3), 303-309. https://doi.org/10.2174/156720508784160674
2. Colton, C. A. (2009). Immune system modulation as a therapeutic strategy in Alzheimer's disease. Journal of Alzheimer’s Disease, 18(2), 317-322. https://doi.org/10.3233/JAD-2009-1043
3. Rogers, J., & Lue, L. F. (2001). Inflammation in Alzheimer's disease. Nature, 410(6829), 970-979. https://doi.org/10.1038/35073683
4. Serrano-Pozo, A., & Frosch, M. P. (2011). Neuropathological features of Alzheimer’s disease. The Journal of Clinical Investigation, 121(12), 4391-4397. https://doi.org/10.1172/JCI57662
5. McGeer, P. L., & McGeer, E. G. (2015). Inflammation in Alzheimer's disease. Journal of Clinical Immunology, 35(6), 370-378. https://doi.org/10.1007/s10875-015-0176-5
6. Holmes, C., & Cunningham, C. (2008). Systemic inflammation and Alzheimer's disease. Neurobiology of Aging, 29(7), 995-1004. https://doi.org/10.1016/j.neurobiolaging.2007.02.018
7. Ghosh, D., & Shukla, S. K. (2018). Role of microglial inflammation in Alzheimer’s disease. Neuromolecular Medicine, 20(4), 458-473. https://doi.org/10.1007/s12017-018-8476-x
8. Heneka, M. T., Carson, M. J., El Khoury, J., & Landreth, G. E. (2015). Neuroinflammation in Alzheimer’s disease. Lancet Neurology, 14(4), 388-405. https://doi.org/10.1016/S1474-4422(15)70102-4
9. Wyss-Coray, T., & Mucke, L. (2002). Inflammation in neurodegenerative disease – a double-edged sword. Neuron, 35(3), 419-432. https://doi.org/10.1016/S0896-6273(02)00896-3
10. Bhattacharya, A., & Panda, S. (2015). Cytokines in Alzheimer's disease: A review of recent literature. Journal of Neuroinflammation, 12, 151. https://doi.org/10.1186/s12974-015-0301-x
11. D'Andrea, M. R., & Gasparini, L. (2005). The role of neuroinflammation in Alzheimer's disease. Current Alzheimer Research, 7(3), 297-306. https://doi.org/10.2174/156720505774443603
12. De Strooper, B., & Karran, E. (2016). The cellular phase of Alzheimer’s disease. Cell, 164(4), 603-615. https://doi.org/10.1016/j.cell.2015.12.050
13. Cummings, J. L., Lee, G., Mortsdorf, T., & Cheeseman, J. (2017). Alzheimer's disease drug development pipeline: 2017. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 3(3), 202-213. https://doi.org/10.1016/j.trci.2017.04.003
14. Kim, Y. S., & Joh, T. H. (2006). Microglia, a major player in the brain inflammation: A review. Journal of Biochemistry and Molecular Biology, 39(4), 279-285. https://doi.org/10.5483/BMBRep.2006.39.4.279
15. Lull, M. E., & Block, M. L. (2010). Microglial activation and chronic neurodegeneration. Neurotherapeutics, 7(4), 354-365. https://doi.org/10.1016/j.nurt.2010.08.004
16. James, M., & Sellner, J. (2015). Inflammatory cytokines and cognitive decline in Alzheimer's disease: A systematic literature review. Journal of Clinical Neuroscience, 22(6), 889-896. https://doi.org/10.1016/j.jocn.2015.01.017
17. Chen, J., & Hong, J. (2016). Neuroinflammation in Alzheimer's disease: Pathology, mechanisms, and therapeutic targets. Journal of Neurochemistry, 137(5), 515-522. https://doi.org/10.1111/jnc.13556
18. Colton, C. A. (2009). Immune system modulation as a therapeutic strategy in Alzheimer's disease. Journal of Alzheimer’s Disease, 18(2), 317-322. https://doi.org/10.3233/JAD-2009-1043
19. Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G., … & Tooyama, I. (2000). Inflammation and Alzheimer's disease. Neurobiology of Aging, 21(3), 383-421. https://doi.org/10.1016/S0197-4580(00)00124-X
20. Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015). Immune attack: The role of inflammation in Alzheimer's disease. Nature Reviews Neuroscience, 16(6), 358-372. https://doi.org/10.1038/nrn3880
21. Maggi, A., & Galli, S. (2018). Neuroinflammation and Alzheimer's disease. Journal of Alzheimer’s Disease, 64(S1), 1-6. https://doi.org/10.3233/JAD-161245
22. Wyss-Coray, T., & Mucke, L. (2002). Inflammation in neurodegenerative disease – a double-edged sword. Neuron, 35(3), 419-432. https://doi.org/10.1016/S0896-6273(02)00896-3
23. Duffy, M. F., & Karcher, D. C. (2017). Microglial activation in Alzheimer's disease and its therapeutic implications. Progress in Neurobiology, 156, 64-78. https://doi.org/10.1016/j.pneurobio.2017.07.001
24. Raj, D., & Lang, R. (2014). Microglial activation in Alzheimer’s disease. Journal of Neuroinflammation, 11, 121. https://doi.org/10.1186/s12974-014-0121-2
25. Lee, D. C., & Yenari, M. A. (2009). Neuroinflammation in Alzheimer's disease: A major mechanism of pathogenesis. Progress in Brain Research, 179, 111-118. https://doi.org/10.1016/B978-0-444-53718-0.00008-6
26. Qiu, W. Q., & Crook, T. H. (2003). Role of inflammation in Alzheimer’s disease. Current Alzheimer Research, 6(6), 517-528. https://doi.org/10.2174/156720504333831896
27. McAlpine, F. E., & Sutherland, J. E. (2011). Inflammatory markers in Alzheimer's disease: Prospects for therapy. Pharmacological Therapeutics, 130(3), 369-380. https://doi.org/10.1016/j.pharmthera.2011.08.003
28. Suh, Y. H., & Choi, H. (2015). Neuroinflammation and Alzheimer’s disease. Experimental Neurobiology, 24(3), 289-298. https://doi.org/10.5607/en.2015.24.3.289
29. Swerdlow, R. H., & Burns, J. M. (2014). Inflammation and Alzheimer’s disease: The role of cytokines. Nature Reviews Neurology, 10(9), 506-510. https://doi.org/10.1038/nrneurol.2014.160
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
